Literature DB >> 23595199

High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

Julia Marie Colston1, Matthew Scarborough, Jane Collier, Ian C J W Bowler.   

Abstract

A 67-year-old gentleman developed persistent Staphylococcus epidermidis bacteraemia following transjugular intrahepatic portal shunting. 'Endotipsitis' was diagnosed. Conventional therapy with a vancomycin infusion, amikacin and rifampicin failed after 17 days. He was cured with a 6-week course of high-dose (8 mg/kg) daptomycin monotherapy.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23595199      PMCID： PMC3645644          DOI： 10.1136/bcr-2013-009529

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  13 in total

1.  Safety analysis of high dose (>6 mg/kg/day) daptomycin in patients with concomitant statin therapy.

Authors:  J Parra-Ruiz; C Dueñas-Gutiérrez; C Tomás-Jiménez; J P Linares-Palomino; J Garrido-Gomez; J Hernández-Quero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-08       Impact factor: 3.267

2.  Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Authors:  Meir Mizrahi; Lilach Roemi; Daniel Shouval; Tomer Adar; Maya Korem; Alon Moses; Alan Bloom; Oren Shibolet
Journal:  World J Hepatol       Date:  2011-05-27

3.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Authors:  Vance G Fowler; Helen W Boucher; G Ralph Corey; Elias Abrutyn; Adolf W Karchmer; Mark E Rupp; Donald P Levine; Henry F Chambers; Francis P Tally; Gloria A Vigliani; Christopher H Cabell; Arthur Stanley Link; Ignace DeMeyer; Scott G Filler; Marcus Zervos; Paul Cook; Jeffrey Parsonnet; Jack M Bernstein; Connie Savor Price; Graeme N Forrest; Gerd Fätkenheuer; Marcelo Gareca; Susan J Rehm; Hans Reinhardt Brodt; Alan Tice; Sara E Cosgrove
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

4.  High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.

Authors:  Ravina Kullar; Susan L Davis; Donald P Levine; Jing J Zhao; Christopher W Crank; John Segreti; George Sakoulas; Sara E Cosgrove; Michael J Rybak
Journal:  Pharmacotherapy       Date:  2011-06       Impact factor: 4.705

Review 5.  Biofilm in implant infections: its production and regulation.

Authors:  J W Costerton; L Montanaro; C R Arciola
Journal:  Int J Artif Organs       Date:  2005-11       Impact factor: 1.595

6.  Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors:  Molly E Steed; Brian J Werth; Cortney E Ireland; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 7.  Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management.

Authors:  Meir Mizrahi; Tomer Adar; Daniel Shouval; Allan I Bloom; Oren Shibolet
Journal:  Liver Int       Date:  2009-11-19       Impact factor: 5.828

8.  Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  Warren E Rose; Steven N Leonard; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

9.  β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

Authors:  Shrenik Mehta; Christopher Singh; Konrad B Plata; Palas K Chanda; Arundhati Paul; Sarah Riosa; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2012-09-17       Impact factor: 5.191

Review 10.  Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature.

Authors:  Paul K Armstrong; Colin MacLeod
Journal:  Clin Infect Dis       Date:  2003-01-24       Impact factor: 9.079
View more
  3 in total

1.  Endotipsitis: A case report with a literature review on an emerging prosthetic related infection.

Authors:  Annalan Md Navaratnam; Matthew Grant; David B Banach
Journal:  World J Hepatol       Date:  2015-04-08

2.  Late polymicrobial transjugular intrahepatic portosystemic shunt infection in a liver transplant patient: A case report.

Authors:  Irene Caridad Perez; Ziv J Haskal; John I Hogan; Curtis K Argo
Journal:  World J Hepatol       Date:  2022-04-27

3.  Antimicrobial Stewardship Intervention and Feedback to Infectious Disease Specialists: A Case Study in High-Dose Daptomycin.

Authors:  Jennifer L Ross; Shannon Rankin; Patricia Marshik; Renée-Claude Mercier; Meghan Brett; Carla J Walraven
Journal:  Antibiotics (Basel)       Date:  2015-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.